THE SHARE: Change: -0.02 SEK (-9.32%) / Price: 0.20 SEK / Sep 25, 2025, 5:29 pm (CEST)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
    • Corporate Governance
    • Career
  • Technology
    • Physiological Targeting
    • Functional Nanoparticles
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Financial Calendar
    • Equity research
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Spago Nanomedical in media
    • Press Releases
    • Subscribe
    • Presentations
    • Events
    • Image Bank
  • Contact
    • Contact us

Press Releases

  • 11 Dec, 2013
    Accelerator och Spago klara med överlåtelsen av Archaea Pharma
  • 29 Oct, 2013
    Ändrat rapportdatum för bokslutskommuniké 2013
  • 29 Oct, 2013
    Delårsrapport januari – september 2013
  • 11 Oct, 2013
    Accelerator och Spago offentliggör villkoren i överlåtelseavtal gällande aktier i Archaea Pharma
  • 29 Aug, 2013
    Delårsrapport januari – juni 2013
  • 29 Aug, 2013
    Good results achieved in tolerance studies for the new generation of SPAGO Pix
  • 29 Aug, 2013
    God tolerans uppnådd med ny generation av kontrastmedlet SPAGO Pix
  • 24 May, 2013
    Delårsrapport januari – mars 2013
  • 22 May, 2013
    Ny generation kontrastmedel verifierad i MR-kamera
  • 25 Apr, 2013
    Kommuniké från årsstämma i Spago Imaging AB
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • Previous
  • Next
Back

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2025 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications